tiprankstipranks
pc:amb0u

Ambrosia Biosciences Inc

Ambrosia Biosciences Inc. is a clinical-stage biopharmaceutical company developing oral small molecule therapies targeting cardiometabolic diseases. The company is advancing an oral small molecule GLP-1 candidate and other novel cardiometabolic programs toward clinical development.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$100M
Total Amount Raised$100M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$100M
Latest Funding Amount$100M
Latest Funding RoundSeries B
Latest Funding RoundSeries B
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Mar 31, 2026
Series B
$100.00M

Related News and Analysis